title: Characterization of Mycobacterium tuberculosis complex isolated from iranian and afghani patients by spoligotyping method.
abstract: Designing newer drugs, vaccines, and diagnostic techniques is dependent on better understanding of M. tuberculosis virulence mechanism. In this study the prevalence of pcaA gene was determined in M. tuberculosis strains typed by spoligotyping. The associated risk factors among patients with different nationalities residing in Iran were also determined. The isolated M. tuberculosis strains have been characterized by performing susceptibility tests against four first-line antituberculosis drugs and were then subjected to spoligotyping characterization. PCR was used for detection of pcaA gene and its nucleotide sequence was also determined. Spoligotyping of M. tuberculosis strains resulted in 140 different patterns. One hundred twenty two (87.1%) of these spoligotype isolates were unique and reported for the first time. The remaining18 (12.8%) spoligotype patterns were previously reported from other geographical regions of the world. Haarlem family was most prevalent than other genotype. Antibiotic resistances were higher in those isolated from the Iranian patients. The pcaA gene was detected in M. tuberculosis clinical isolates but not in saprophyte strains such as M. kansasi. The results showed that, spread of M. tuberculosis strains belonging to the Beijing family among Iranian patients has to be considered seriously. This study confirmed the widespread existence of pcaA gene in almost all the clinical isolates. It is also important to undertake studies to identify which factors are the most significant to consider in tuberculosis control program.
authors.affiliation: Microbiology Department, Faculty of Medicine, Kurdistan University of Medical Science , Sanandaj- Iran.
authors.forename: Rashid
authors.initials: R
authors.lastname: Ramazanzadeh
authors.forename: Parisa
authors.initials: P
authors.lastname: Farnia
authors.forename: Nour
authors.initials: N
authors.lastname: Amirmozafari
keywords: drugs; pcaA; resistance; spoligotyping; tuberculosis
references.citation: Scand J Infect Dis. 2002;34(3):163-6
references.pmid: 12030386
references.citation: J Bacteriol. 1979 Jul;139(1):205-11
references.pmid: 110779
references.citation: J Clin Microbiol. 2000 Feb;38(2):669-76
references.pmid: 10655365
references.citation: Int J Tuberc Lung Dis. 2004 Jul;8(7):837-41
references.pmid: 15260274
references.citation: J Clin Microbiol. 1999 Feb;37(2):471-4
references.pmid: 9889247
references.citation: BMC Microbiol. 2006 Mar 06;6:23
references.pmid: 16519816
references.citation: J Clin Microbiol. 1997 Apr;35(4):907-14
references.pmid: 9157152
references.citation: J Biol Chem. 2001 Jan 19;276(3):2228-33
references.pmid: 11092877
references.citation: Int J Tuberc Lung Dis. 2001 Mar;5(3):216-9
references.pmid: 11326819
references.citation: Schweiz Med Wochenschr. 2000 Dec 9;130(49):1909-13
references.pmid: 11153397
references.citation: J Clin Microbiol. 1991 Nov;29(11):2578-86
references.pmid: 1685494
references.citation: J Biol Chem. 1997 Apr 11;272(15):10041-9
references.pmid: 9092547
references.citation: J Clin Microbiol. 2003 Feb;41(2):694-702
references.pmid: 12574269
references.citation: Infect Genet Evol. 2005 Oct;5(4):340-8
references.pmid: 16168940
references.citation: J Biol Chem. 2002 Mar 29;277(13):11559-69
references.pmid: 11756461
references.citation: J Clin Microbiol. 2002 Jun;40(6):1930-7
references.pmid: 12037045
references.citation: Annu Rev Biochem. 1995;64:29-63
references.pmid: 7574484
references.citation: J Clin Microbiol. 1993 Feb;31(2):406-9
references.pmid: 8381814
references.citation: Eur Respir J. 1998 Apr;11(4):795-7
references.pmid: 9623677
references.citation: Arch Dis Child. 2003 Dec;88(12):1106-11
references.pmid: 14670781
references.citation: J Clin Microbiol. 1995 Dec;33(12):3234-8
references.pmid: 8586708
references.citation: Emerg Infect Dis. 2002 Aug;8(8):843-9
references.pmid: 12141971
references.citation: Braz J Microbiol. 2008 Apr;39(2):209-13
references.pmid: 24031203
references.citation: Ann Clin Microbiol Antimicrob. 2002 Dec 16;1:6
references.pmid: 12537590
references.citation: Proc Natl Acad Sci U S A. 1997 Sep 2;94(18):9869-74
references.pmid: 9275218
references.citation: Mol Cell. 2000 Apr;5(4):717-27
references.pmid: 10882107
references.citation: J Clin Microbiol. 2005 Apr;43(4):1617-24
references.pmid: 15814975
references.citation: Braz J Microbiol. 2008 Jan;39(1):16-20
references.pmid: 24031169
references.citation: BMC Microbiol. 2003 Jun 16;3:12
references.pmid: 12809568
references.citation: J Formos Med Assoc. 2004 Sep;103(9):671-7
references.pmid: 15361939
references.citation: J Clin Microbiol. 2001 Oct;39(10):3563-71
references.pmid: 11574573
references.citation: J Bacteriol. 2003 Apr;185(8):2555-62
references.pmid: 12670980
references.citation: Bioinformatics. 2002 Feb;18(2):235-43
references.pmid: 11847071
references.citation: Int J Tuberc Lung Dis. 1997 Aug;1(4):370-6
references.pmid: 9432395
references.citation: Proc Natl Acad Sci U S A. 1996 Nov 12;93(23):12828-33
references.pmid: 8917504
references.citation: J Biol Chem. 2003 Mar 7;278(10):7844-9
references.pmid: 12502719